PERRIGO Co plc (PRGO): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
PERRIGO Co plc (PRGO) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K PERRIGO Co plc 00-0000000 353 false 0001585364 0001585364 2026-06-07 2026-06-07 0001585364 prgo:OrdinaryShares0001ParValueMember 2026-06-07 2026-06-07 0001585364 prgo:A4.900SeniorNotesDueJune152030Member 2026-06-07 2026-06-07 0001585364 prgo:A6.125SeniorNotesDue2032Member 202
How this was made
The 30-second read
Why it matters
The immediate CEO departure for conduct reasons is a governance headline, but the company emphasizes it is not tied to performance or strategy. Traders may focus on interim leadership credibility, audit committee transition, and forthcoming compensation terms within days.
Market read
Company-specific governance/execution risk repricing is the main near-term trading driver; no operational or financial guidance changes are provided in the filing.
What to watch
Compensation arrangements for the interim CEO are not yet definitively determined; the permanent CEO search process and any subsequent disclosures could be the next tradable catalyst.
Background
Perrigo filed an SEC 8-K (Item 5.02) detailing the immediate resignation of CEO Patrick Lockwood-Taylor and the appointment of Albert A. Manzone as interim President and CEO, alongside board size reduction.
Ticker impact
Perrigo disclosed CEO Patrick Lockwood-Taylor’s immediate resignation for personal conduct reasons and named Albert Manzone as interim CEO.
Likely short-term volatility around governance/execution concerns; directionally uncertain until compensation terms and search outcomes are clarified.
The filing is a primary-source 8-K with an immediate CEO departure and interim appointment, but it explicitly states no link to strategy/operations/results, and key compensation terms are not yet determined.
Market effects
Leadership turnover at a consumer/healthcare products company can modestly affect perceived execution risk across defensive pharma/OTC peers, but no sector-wide regulatory or product catalyst is cited.
Primarily US-listed equity sentiment; Ireland-incorporated issuer may have limited incremental regional spillover beyond PRGO.
No global operational or strategic deal/regulatory action is described; impact is company-specific.
Counterpoint
Because the company states the resignation is not related to business, strategy, operations, financial reporting, or results, the market may over-discount the event versus the actual operational risk.
Key entities
- issuerPerrigo Company plc
US-listed company (PRGO) filing the 8-K about CEO departure and interim CEO appointment.
- executivePatrick Lockwood-Taylor
Resigned effective immediately as President and CEO and as a board member; resignation follows board determination of conduct inconsistency with code of conduct.
- executiveAlbert A. Manzone
Appointed Interim President and CEO; will step down from the Audit Committee during interim service; comprehensive search initiated for permanent CEO.
